Asad Haider
Stock Analyst at Goldman Sachs
(1.97)
# 1210
Out of 5,368 analysts
6
Total ratings
100.00%
Success rate
8.44%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BNTX BioNTech | Initiates Coverage On: Neutral | 110 | 106.58 | 3.21% | 1 | May 29, 2025 | |
JNJ Johnson & Johnson | Upgrades: Buy | 157 172 | 157.04 | 9.53% | 1 | Apr 9, 2025 | |
LLY Eli Lilly | Upgrades: Buy | 892 888 | 819.67 | 8.34% | 1 | Apr 8, 2025 | |
ABBV AbbVie | Assumes: Neutral | 194 | 190.93 | 1.61% | 1 | Apr 8, 2025 | |
PFE Pfizer | Downgrades: Neutral | 32 25 | 24.52 | 1.96% | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 67 55 | 49.73 | 10.6% | 1 | Apr 8, 2025 |